Floatz logo

Molgramostim

Mycobacterium Infections, Nontuberculous

Savara Inc.protein_peptidePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Mycobacterium Infections, Nontuberculous cohort.

Asset / SponsorPhaseRating
Molgramostim Nebulizer
Savara Inc.
Phase 2CCC

Same molecule, other indications

Molgramostim is also rated in:

cystic fibrosisDormant
CCC
Indicative ·
55 / 100
View asset →
cutaneous melanomaDormant
CCC
Indicative ·
55 / 100
View asset →
Malignant AscitesDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →